Centersquare Investment Management LLC Raises Holdings in Ventas, Inc. $VTR

Centersquare Investment Management LLC increased its position in Ventas, Inc. (NYSE:VTR) by 0.1% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 6,491,417 shares of the real estate investment trust’s stock after purchasing an additional 7,300 shares during the quarter. Ventas makes up 5.0% of Centersquare Investment Management LLC’s holdings, making the stock its 5th largest position. Centersquare Investment Management LLC owned about 1.37% of Ventas worth $502,306,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of the stock. Bridgewater Advisors Inc. raised its holdings in Ventas by 2.0% in the 4th quarter. Bridgewater Advisors Inc. now owns 6,790 shares of the real estate investment trust’s stock valued at $525,000 after acquiring an additional 133 shares during the period. True Wealth Design LLC raised its holdings in Ventas by 32.0% in the 4th quarter. True Wealth Design LLC now owns 569 shares of the real estate investment trust’s stock valued at $44,000 after acquiring an additional 138 shares during the period. Cigna Investments Inc. New raised its holdings in Ventas by 3.3% in the 4th quarter. Cigna Investments Inc. New now owns 4,396 shares of the real estate investment trust’s stock valued at $341,000 after acquiring an additional 142 shares during the period. Parallel Advisors LLC raised its holdings in Ventas by 4.6% in the 3rd quarter. Parallel Advisors LLC now owns 3,970 shares of the real estate investment trust’s stock valued at $278,000 after acquiring an additional 175 shares during the period. Finally, HighTower Advisors LLC raised its holdings in Ventas by 0.4% in the 3rd quarter. HighTower Advisors LLC now owns 42,092 shares of the real estate investment trust’s stock valued at $2,946,000 after acquiring an additional 182 shares during the period. 94.18% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, Director Walter C. Rakowich sold 1,152 shares of the business’s stock in a transaction on Thursday, May 14th. The shares were sold at an average price of $90.20, for a total value of $103,910.40. Following the sale, the director owned 28,349 shares of the company’s stock, valued at $2,557,079.80. The trade was a 3.90% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael J. Embler acquired 2,500 shares of Ventas stock in a transaction that occurred on Wednesday, June 3rd. The stock was acquired at an average cost of $78.81 per share, for a total transaction of $197,025.00. Following the purchase, the director owned 19,202 shares of the company’s stock, valued at $1,513,309.62. The trade was a 14.97% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Company insiders own 0.53% of the company’s stock.

Analysts Set New Price Targets

VTR has been the topic of several recent research reports. Jefferies Financial Group raised their target price on shares of Ventas from $97.00 to $100.00 and gave the stock a “buy” rating in a report on Tuesday, May 12th. Wells Fargo & Company lifted their price objective on shares of Ventas from $93.00 to $96.00 and gave the company an “overweight” rating in a research note on Monday, June 1st. The Goldman Sachs Group reissued a “buy” rating and issued a $110.00 price objective on shares of Ventas in a research note on Tuesday, May 19th. Scotiabank lifted their price objective on shares of Ventas from $93.00 to $95.00 and gave the company a “sector perform” rating in a research note on Thursday, May 21st. Finally, Citigroup lifted their price objective on shares of Ventas from $96.00 to $100.00 and gave the company a “buy” rating in a research note on Friday, May 1st. Fourteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $95.19.

Ventas Stock Performance

Shares of Ventas stock opened at $83.69 on Friday. Ventas, Inc. has a fifty-two week low of $61.76 and a fifty-two week high of $91.06. The company has a debt-to-equity ratio of 0.95, a current ratio of 0.25 and a quick ratio of 0.25. The firm has a market capitalization of $40.69 billion, a P/E ratio of 152.17, a P/E/G ratio of 1.81 and a beta of 0.71. The company’s 50 day moving average price is $85.10 and its two-hundred day moving average price is $82.47.

Ventas (NYSE:VTR) last issued its earnings results on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). Ventas had a net margin of 4.25% and a return on equity of 2.09%. The company had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.59 billion. During the same quarter in the prior year, the business earned $0.84 EPS. The business’s quarterly revenue was up 22.0% on a year-over-year basis. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. On average, equities analysts forecast that Ventas, Inc. will post 3.88 earnings per share for the current fiscal year.

Ventas Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, July 16th. Shareholders of record on Tuesday, June 30th will be given a $0.52 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $2.08 dividend on an annualized basis and a yield of 2.5%. Ventas’s dividend payout ratio (DPR) is currently 378.18%.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.